Despite widespread use of unfractionated heparin for a variety of thrombotic disorders, the
frequency of heparin induced thrombocytopenia (HIT) is underappreciated by many …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated hypercoagulable disorder
caused by antibodies to platelet factor 4 (PF4) and heparin. HIT develops in temporal …

INTRODUCTION Heparin-induced thrombocytopenia (HIT) is a distinct clinicopathologic
syndrome caused by platelet-activating antibodies that recognize complexes of platelet …

Heparin-induced thrombocytopenia (HIT) is an immunemediated complication of heparin
therapy. The diagnosis of HIT is based on the clinical findings supported by laboratory …

Heparin-induced thrombocytopenia (HIT) is a" clinical-pathological" syndrome (1, 2). This
means that to diagnose HIT a patient must both exhibit a clinical picture compatible with this …

Heparin induced thrombocytopenia is a serious side effect of a drug that is widely used in
clinical practice. All patients exposed to heparin, administered by any route or at any dose …

Heparin-induced thrombocytopenia (HIT) is an immune response to heparin that can
progress to severe thrombosis, amputation, and in some cases death. The diagnosis and …

Heparin-induced thrombocytopenia (HIT) represents an immune reaction to heparin, which if
unrecognized and untreated, has the potential for catastrophic thrombotic events. The …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated adverse effect of heparin
that is important because of its relatively high frequency and its strong association with …

Heparin-induced thrombocytopenia (HIT) is a severe complication of heparin therapy. Life-
threatening thromboembolism (HITT) may occur in a large number of patients with HIT. In …